Current role
Kristen Pierce
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kristen Pierce
Cero Therapeutics Holdings, Inc. reported in an 8-K filed October 2, 2024 that Kristen Pierce was appointed Chief Development Officer. The proxy statement of Cero Therapeutics Holdings, Inc. reports total compensation of $119,777 for Kristen Pierce in fiscal 2024, including a base salary of $90,000.
“Andrew Albert "Al" Kucharchuk has been named Chief Financial Officer and Kristen Pierce, Ph.D., has been appointed Chief Development Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cero Therapeutics Holdings, Inc. (CERO)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cero Therapeutics Holdings, Inc. (CERO) | Chief Development Officer | $90,000 | $119,777 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.